A 28-year-old woman with HIV-1 infection (CD4 count 180 cells/μL, viral load 200,000 copies/mL) is pregnant at 18 weeks gestation. She has never received antiretroviral therapy. Which of the following is the preferred first-line regimen to prevent mother-to-child transmission (PMTCT) and treat her advanced immunosuppression?